ORAGENICS, INC. Stock Issued During Period, Shares, Conversion of Units
ORAGENICS, INC. (OGEN) reported Stock Issued During Period, Shares, Conversion of Units of 13.50 thousand shares for the 0-month period ending 2017-11-08, per its 10-Q filed 2023-05-12.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits · last filed 2023-05-12
- 2017-11-08: Stock Issued During Period, Shares, Conversion of Units 0 month 13.50K shares.
- 2014-01-13: Stock Issued During Period, Shares, Conversion of Units 135.00K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Units 0 month | Stock Issued During Period, Shares, Conversion of Units |
|---|---|---|
| 2017-11-08 | 13.50K shares 10-Q · filed 2023-05-12 | |
| 2014-01-13 | 135.00K shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |